Thrombophilia Testing in High Pediatric Migraine Risk Children With Migraine

Yoel Levinsky1,2, Avraham Zeharia1,2, Joanne Yacobovich3,2

  • 1Pediatric Headache Clinic, Day Hospitalization Department, Schneider Children's Medical Center of Israel, Petach Tikva, Israel.

Journal of Child Neurology
|November 30, 2018
PubMed

Insights

Routine thrombophilia screening in pediatric migraine patients is not recommended. While some factors were common, elevated Lipoprotein(a) in children with migraine needs more research.

Area of Science:

  • Pediatric Neurology
  • Hematology
  • Genetics

Background:

  • Migraine is common in children.
  • Thrombophilia, a tendency to clot, may be linked to certain conditions.
  • Screening for thrombophilia in pediatric migraineurs is debated.

Purpose of the Study:

  • To determine the necessity of thrombophilia screening in children experiencing migraines.
  • To analyze the prevalence of thrombotic factors in pediatric migraineurs.

Main Methods:

  • Retrospective analysis of 45 pediatric migraine patients (aged 3-18) tested for thrombophilia.
  • Comparison of thrombotic factor rates with a healthy historical control group.
  • Analysis based on patient background and screening indications.

Main Results:

  • 42% of pediatric migraineurs had at least one positive thrombotic factor.
  • Thrombophilia risk was higher in patients with migraine aura.
  • Elevated Lipoprotein(a) was the most frequent abnormality (42%), significantly higher in migraineurs than controls.

Conclusions:

  • Comprehensive thrombophilia testing is not routinely justified for pediatric migraine patients.
  • The elevated prevalence of Lipoprotein(a) in children with migraine requires further investigation.

Related Concept Videos

Relative Risk01:12

Relative Risk

Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
2.1K
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
13.5K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
261
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
295
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
307
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
227